MIRM Stock Analysis: Buy, Sell, or Hold?
MIRM - Mirum Pharmaceuticals, Inc. Common Stock
$119.04
-3.09 (-2.53%)
▼
5d:
-2.35%
30d:
+26.64%
90d:
+25.04%
BUY
HIGH Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 05, 2026
21d
Get Alerted When MIRM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: MIRM shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: MIRM shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: MIRM is currently trading at $119.04, which is considered slightly high relative to its 30-day fair value range of $98.78 to $123.40. From a valuation perspective, the stock is trading at a discount (Forward PE: -633.2) compared to its historical average (185.2). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MIRM is in a strong uptrend. The price is currently testing key support at $115.73. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $146.50 (+23.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MIRM is in a strong uptrend. The price is currently testing key support at $115.73. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $146.50 (+23.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$98.78 -
$123.40
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
75.8%
All Signals
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.1% below Wall St target ($146.50)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Trading Range Analysis
30-Day Trading Range
$98.78 -
$123.40
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
±$7.93
(6.7%)
Support & Resistance Levels
Support Level
$115.73
Resistance Level
$130.00
Current Trend
Strong Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-633.19
Wall Street Target
$146.50
(+23.1%)
Revenue Growth (YoY)
43.3%
Profit Margin
-140.2%
PE vs Historical
-633.2 vs 185.2
CHEAP
Share & Embed Analysis
Last updated: July 13, 2026 10:25 PM ET
Data refreshes hourly during market hours. Next update: 11:25 PM
Data refreshes hourly during market hours. Next update: 11:25 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MIRM showing a specific setup today?
Insider Activity (6 Months)
1
Buys
18
Sells
Net
INSIDERS SELLING
Recent Transactions
Eric Bjerkholt
SELL
7287 shares
2026-03-16
Joanne Quan
SELL
7287 shares
2026-03-16
Jolanda Howe
SELL
4732 shares
2026-03-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$258 | 67 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$128 | 59 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 49 HOLD |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 54 HOLD |
|
XNCR
Xencor Inc |
STRONG BUY
12 analysts |
$28 | 61 BUY |
Advanced MIRM Option Strategies
Professional options setups generated by AI based on today's MIRM price and gamma walls.
